This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ashvattha Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Sujatha Kannan: Innovator in Severe Inflammation Treatment
Introduction
Sujatha Kannan is a notable inventor based in Redwood City, CA (US). She has made significant contributions to the field of medical treatments, particularly in addressing severe inflammation. Her innovative approach has the potential to impact the lives of many individuals suffering from serious respiratory conditions.
Latest Patents
Sujatha Kannan holds a patent for "Methods of treating severe inflammation." This patent describes a method for treating or preventing symptoms of severe inflammation in the lungs. The method involves administering a composition that includes dendrimers complexed, covalently conjugated, or encapsulated with therapeutic agents. This approach is particularly useful for treating disorders characterized by cytokine storms, such as acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), which can arise from infections like COVID-19 or sepsis. The patent emphasizes the use of generation 4 to 8 poly(amidoamine) (PAMAM) dendrimers and includes anti-inflammatory and antioxidant agents like N-acetyl cysteine.
Career Highlights
Sujatha Kannan has established herself as a key figure in her field through her innovative research and development efforts. Her work at Ashvattha Therapeutics, Inc. showcases her commitment to advancing medical treatments. With her expertise, she has contributed to the understanding and potential solutions for severe inflammatory conditions.
Collaborations
Sujatha collaborates with Jeffrey L Cleland, further enhancing her research and development efforts. Their partnership exemplifies the importance of teamwork in driving innovation in the medical field.
Conclusion
Sujatha Kannan's contributions to the treatment of severe inflammation highlight her role as an influential inventor. Her patented methods and ongoing work at Ashvattha Therapeutics, Inc. demonstrate her dedication to improving health outcomes for individuals facing serious respiratory challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile